Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mihai S Cirstea

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Innate Immunity|January 13, 2016
Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during SepsisJohn H Boyd, Christopher D Fjell, James A Russell, et al.
Journal of Parkinson'S Disease|November 9, 2020
The Gut Mycobiome in Parkinson's DiseaseMihai S Cirstea, Kristen Sundvick, Ella Golz, et al.
Ebiomedicine|November 27, 2018
Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivorsKelly Roveran Genga, Cody Lo, Mihai S Cirstea, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 2, 2020
Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's DiseaseMihai S Cirstea, Adam C Yu, Ella Golz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 5, 2021
Reply to: 'Comment on "Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease"'Mihai S Cirstea, Adam C Yu, Ella Golz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 28, 2024
Metagenomic Analysis Reveals Large-Scale Disruptions of the Gut Microbiome in Parkinson's DiseaseAvril Metcalfe-Roach, Mihai S Cirstea, Adam C Yu, et al.
Journal of Parkinson'S Disease|February 4, 2026
A randomized safety and feasibility crossover trial of two Mediterranean-ketogenic interventions in individuals with Parkinson's diseaseKira Tosefsky, Joyce St Lam, Yolanda N Wang, et al.
NPJ Parkinson'S Disease|April 25, 2026
Probiotic supplementation for anxiety symptoms in people with Parkinson's disease: a randomized, double-blind, placebo-controlled trialJoyce S T Lam, Kira N Tosefsky, Nicholas J Ainsworth, et al.
Journal of Alzheimer'S Disease : JAD|March 11, 2022
The Oral and Fecal Microbiota in a Canadian Cohort of Alzheimer's DiseaseMihai S Cirstea, Daniel Kliger, Abbey D MacLellan, et al.
Science Translational Medicine|October 17, 2014
PCSK9 is a critical regulator of the innate immune response and septic shock outcomeKeith R Walley, Katherine R Thain, James A Russell, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Innate Immunity|January 13, 2016
Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during SepsisJohn H Boyd, Christopher D Fjell, James A Russell, et al.
Journal of Parkinson'S Disease|November 9, 2020
The Gut Mycobiome in Parkinson's DiseaseMihai S Cirstea, Kristen Sundvick, Ella Golz, et al.
Ebiomedicine|November 27, 2018
Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivorsKelly Roveran Genga, Cody Lo, Mihai S Cirstea, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 2, 2020
Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's DiseaseMihai S Cirstea, Adam C Yu, Ella Golz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 5, 2021
Reply to: 'Comment on "Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease"'Mihai S Cirstea, Adam C Yu, Ella Golz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 28, 2024
Metagenomic Analysis Reveals Large-Scale Disruptions of the Gut Microbiome in Parkinson's DiseaseAvril Metcalfe-Roach, Mihai S Cirstea, Adam C Yu, et al.
Journal of Parkinson'S Disease|February 4, 2026
A randomized safety and feasibility crossover trial of two Mediterranean-ketogenic interventions in individuals with Parkinson's diseaseKira Tosefsky, Joyce St Lam, Yolanda N Wang, et al.
NPJ Parkinson'S Disease|April 25, 2026
Probiotic supplementation for anxiety symptoms in people with Parkinson's disease: a randomized, double-blind, placebo-controlled trialJoyce S T Lam, Kira N Tosefsky, Nicholas J Ainsworth, et al.
Journal of Alzheimer'S Disease : JAD|March 11, 2022
The Oral and Fecal Microbiota in a Canadian Cohort of Alzheimer's DiseaseMihai S Cirstea, Daniel Kliger, Abbey D MacLellan, et al.
Science Translational Medicine|October 17, 2014
PCSK9 is a critical regulator of the innate immune response and septic shock outcomeKeith R Walley, Katherine R Thain, James A Russell, et al.
Pageof 2